In BCa, it has been demonstrated that the serum level and tissue expression of TGF-β1 is significantly elevated [27, 28], and increased levels of TGF-β in patients with bladder cancer have significant prognostic value for highly aggressive metastatic disease and are considered a poor prognosis marker [8, 29]. Here, TGFB1 is linked to urinary bladder cancer.